Cargando…
Recent advances in understanding and managing diverticulitis
In the past few decades, the increasing socioeconomic burden of acute diverticulitis (AD) has become evident, and with the growth of the population age, this significant economic impact will likely continue to rise. Furthermore, recent evidence showed an increased rate of hospital admissions especia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039950/ https://www.ncbi.nlm.nih.gov/pubmed/30026920 http://dx.doi.org/10.12688/f1000research.14299.1 |
_version_ | 1783338771159187456 |
---|---|
author | Severi, Carola Carabotti, Marilia Cicenia, Alessia Pallotta, Lucia Annibale, Bruno |
author_facet | Severi, Carola Carabotti, Marilia Cicenia, Alessia Pallotta, Lucia Annibale, Bruno |
author_sort | Severi, Carola |
collection | PubMed |
description | In the past few decades, the increasing socioeconomic burden of acute diverticulitis (AD) has become evident, and with the growth of the population age, this significant economic impact will likely continue to rise. Furthermore, recent evidence showed an increased rate of hospital admissions especially evident among women and younger individuals. The natural history and pathophysiology of this clinical condition is still to be fully defined, and efforts continue to be made in the identification of risk factors and the establishment of relative preventive strategies. The actual therapeutic strategies aimed to modulate gut microbiota, such as rifaximin or probiotics, or to reduce mucosal inflammation, such as mesalazine, present a relatively poor efficacy for both the prevention of the first AD episode (primary prevention) and its recurrence (secondary prevention). In the last few years, the main goal achieved has been in the management of AD in that uncomplicated AD can, to a larger extent, be managed in an outpatient setting with no or little supportive therapy, a strategy that will certainly impact on the health costs of this disease. The problem of AD recurrence remains a topic of debate. The aim of this review is to present updated evidence on AD epidemiology and relative open clinical questions and to analyze in detail predisposing and protective factors with an attempt to integrate their possible modes of action into the several pathogenic mechanisms that have been suggested to contribute to this multifactorial disease. A unifying hypothesis dealing with the colonic luminal and extra-luminal microenvironments separately is provided. Finally, evidence-based changes in therapeutic management will be summarized. Because of an ascertained multifactorial pathogenesis of uncomplicated and complicated AD, it is probable that a single ‘causa prima’ will not be identifiable, and a better stratification of patients could allow one to pursue tailored therapeutic algorithm strategies. |
format | Online Article Text |
id | pubmed-6039950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-60399502018-07-18 Recent advances in understanding and managing diverticulitis Severi, Carola Carabotti, Marilia Cicenia, Alessia Pallotta, Lucia Annibale, Bruno F1000Res Review In the past few decades, the increasing socioeconomic burden of acute diverticulitis (AD) has become evident, and with the growth of the population age, this significant economic impact will likely continue to rise. Furthermore, recent evidence showed an increased rate of hospital admissions especially evident among women and younger individuals. The natural history and pathophysiology of this clinical condition is still to be fully defined, and efforts continue to be made in the identification of risk factors and the establishment of relative preventive strategies. The actual therapeutic strategies aimed to modulate gut microbiota, such as rifaximin or probiotics, or to reduce mucosal inflammation, such as mesalazine, present a relatively poor efficacy for both the prevention of the first AD episode (primary prevention) and its recurrence (secondary prevention). In the last few years, the main goal achieved has been in the management of AD in that uncomplicated AD can, to a larger extent, be managed in an outpatient setting with no or little supportive therapy, a strategy that will certainly impact on the health costs of this disease. The problem of AD recurrence remains a topic of debate. The aim of this review is to present updated evidence on AD epidemiology and relative open clinical questions and to analyze in detail predisposing and protective factors with an attempt to integrate their possible modes of action into the several pathogenic mechanisms that have been suggested to contribute to this multifactorial disease. A unifying hypothesis dealing with the colonic luminal and extra-luminal microenvironments separately is provided. Finally, evidence-based changes in therapeutic management will be summarized. Because of an ascertained multifactorial pathogenesis of uncomplicated and complicated AD, it is probable that a single ‘causa prima’ will not be identifiable, and a better stratification of patients could allow one to pursue tailored therapeutic algorithm strategies. F1000 Research Limited 2018-06-29 /pmc/articles/PMC6039950/ /pubmed/30026920 http://dx.doi.org/10.12688/f1000research.14299.1 Text en Copyright: © 2018 Severi C et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Severi, Carola Carabotti, Marilia Cicenia, Alessia Pallotta, Lucia Annibale, Bruno Recent advances in understanding and managing diverticulitis |
title | Recent advances in understanding and managing diverticulitis |
title_full | Recent advances in understanding and managing diverticulitis |
title_fullStr | Recent advances in understanding and managing diverticulitis |
title_full_unstemmed | Recent advances in understanding and managing diverticulitis |
title_short | Recent advances in understanding and managing diverticulitis |
title_sort | recent advances in understanding and managing diverticulitis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039950/ https://www.ncbi.nlm.nih.gov/pubmed/30026920 http://dx.doi.org/10.12688/f1000research.14299.1 |
work_keys_str_mv | AT severicarola recentadvancesinunderstandingandmanagingdiverticulitis AT carabottimarilia recentadvancesinunderstandingandmanagingdiverticulitis AT ciceniaalessia recentadvancesinunderstandingandmanagingdiverticulitis AT pallottalucia recentadvancesinunderstandingandmanagingdiverticulitis AT annibalebruno recentadvancesinunderstandingandmanagingdiverticulitis |